Profibrotic, inflammatory, hypoxia/redox, and metabolic cues (including PTMs like O-GlcNAc) dynamically tune IGFBP-6 abundance and function across disease states and liver cancers. The gene discussed is IGFBP6; the disease is liver cancer.